Background: Patients with primary cutaneous lymphoma receive immunosuppressive
therapy for long term disease control. Both cutaneous lymphoma and immunosuppressive …

Extracorporeal photopheresis (ECP) is an established, safe, and effective treatment for
cutaneous T‐cell lymphoma (CTCL). There is no published literature reviewing the clinical …

Rationale: Most people infected with SARS-CoV-2 have asymptomatic or minor clinical
manifestations and recover without any aggressive therapy. However, there are patient …

Background Extracorporeal photopheresis (ECP) as a part of multimodality therapy, is one of
the treatments for Sézary syndrome (SS) and advanced stage mycosis fungoides (MF). This …

Background: The optimal approach for adult patients hospitalized with severe and critical
coronavirus disease 2019 (COVID-19), non-responsive to antiviral and immunomodulatory …

INTRODUCTION Extracorporeal photopheresis (ECP) is an immunomodulatory therapy that
has been used in the treatment of cutaneous T-cell lymphoma (CTCL) for over 30 years …

dear editor, Cutaneous t-cell lymphoma (CtCL) is a rare form of non-hodgkin lymphoma
caused by skin-homing t-cells. Mycosis fungoides (MF) and Sezary syndrome (SS), an …

Abstract Coronavirus disease-2019 (COVID-19) is a serious cause of respiratory tract
infection, and its severe course has been associated with some risk factors, including …

Psoriasis is a chronic inflammatory skin disease that is characterized by well-demarcated
erythematous plaques with a silver scale. Although many new and emerging therapeutic …

Background Response rates of approved systemic therapies for cutaneous T-cell lymphoma
(CTCL) hover near 30%, suggesting unmet need. This study describes real-world treatment …